Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neostatin-7 Regulates bFGF-induced Corneal Lymphangiogenesis</title>
<author><name sortKey="Kojima, Takashi" sort="Kojima, Takashi" uniqKey="Kojima T" first="Takashi" last="Kojima">Takashi Kojima</name>
</author>
<author><name sortKey="Azar, Dimitri T" sort="Azar, Dimitri T" uniqKey="Azar D" first="Dimitri T." last="Azar">Dimitri T. Azar</name>
</author>
<author><name sortKey="Chang, Jin Hong" sort="Chang, Jin Hong" uniqKey="Chang J" first="Jin-Hong" last="Chang">Jin-Hong Chang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">18570894</idno>
<idno type="pmc">2579793</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579793</idno>
<idno type="RBID">PMC:2579793</idno>
<idno type="doi">10.1016/j.febslet.2008.06.014</idno>
<date when="2008">2008</date>
<idno type="wicri:Area/Pmc/Corpus">002742</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002742</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Neostatin-7 Regulates bFGF-induced Corneal Lymphangiogenesis</title>
<author><name sortKey="Kojima, Takashi" sort="Kojima, Takashi" uniqKey="Kojima T" first="Takashi" last="Kojima">Takashi Kojima</name>
</author>
<author><name sortKey="Azar, Dimitri T" sort="Azar, Dimitri T" uniqKey="Azar D" first="Dimitri T." last="Azar">Dimitri T. Azar</name>
</author>
<author><name sortKey="Chang, Jin Hong" sort="Chang, Jin Hong" uniqKey="Chang J" first="Jin-Hong" last="Chang">Jin-Hong Chang</name>
</author>
</analytic>
<series><title level="j">FEBS letters</title>
<idno type="ISSN">0014-5793</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Neostatin-7, with an anti-angiogenic potential, is generated from the proteolytic action of matrix metalloproteinase-7 on collagen XVIII. We previously reported that neostatin-7 inhibited angiogenesis <italic>in vitro</italic>
and <italic>in vivo</italic>
. Here we demonstrate that neostatin-7/collagen XVIII may possess anti-lymphangiogenic activities by: 1) corneal micropellet implantation of neostatin-7 reduced bFGF-induced corneal lymphangiogenesis; 2) neostatin-7 bound to VEGF receptor-3 <italic>in vitro</italic>
; and 3) enhanced corneal lymphangiogenesis and VEGF-C expression in collagen XVIII knockout mice in a corneal wounding model. Understanding the mechanism of neostatin-7/collagen XVIII on corneal lymphangiogenesis may provide therapeutic interventions to treat lymphangiogenesis-related disorders, such as lymphedema, transplantation rejection and cancers.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article" xml:lang="EN"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">0155157</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3696</journal-id>
<journal-id journal-id-type="nlm-ta">FEBS Lett</journal-id>
<journal-title>FEBS letters</journal-title>
<issn pub-type="ppub">0014-5793</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">18570894</article-id>
<article-id pub-id-type="pmc">2579793</article-id>
<article-id pub-id-type="manuscript">NIHMS59801</article-id>
<article-id pub-id-type="doi">10.1016/j.febslet.2008.06.014</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Neostatin-7 Regulates bFGF-induced Corneal Lymphangiogenesis</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Kojima</surname>
<given-names>Takashi</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Azar</surname>
<given-names>Dimitri T.</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author"><name><surname>Chang</surname>
<given-names>Jin-Hong</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="A1">From the Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, USA</aff>
</contrib-group>
<author-notes><corresp id="cor1"><label>*</label>
Corresponding author: Jin-Hong Chang, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 W. Taylor Street, Chicago, IL 60612. Phone: 312-413-5590; Fax: 312-996-7770; E-mail: <email>changr@uic.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>29</day>
<month>7</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub"><day>18</day>
<month>6</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="ppub"><day>23</day>
<month>7</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>23</day>
<month>7</month>
<year>2009</year>
</pub-date>
<volume>582</volume>
<issue>17</issue>
<fpage>2515</fpage>
<lpage>2520</lpage>
<abstract><p id="P1">Neostatin-7, with an anti-angiogenic potential, is generated from the proteolytic action of matrix metalloproteinase-7 on collagen XVIII. We previously reported that neostatin-7 inhibited angiogenesis <italic>in vitro</italic>
and <italic>in vivo</italic>
. Here we demonstrate that neostatin-7/collagen XVIII may possess anti-lymphangiogenic activities by: 1) corneal micropellet implantation of neostatin-7 reduced bFGF-induced corneal lymphangiogenesis; 2) neostatin-7 bound to VEGF receptor-3 <italic>in vitro</italic>
; and 3) enhanced corneal lymphangiogenesis and VEGF-C expression in collagen XVIII knockout mice in a corneal wounding model. Understanding the mechanism of neostatin-7/collagen XVIII on corneal lymphangiogenesis may provide therapeutic interventions to treat lymphangiogenesis-related disorders, such as lymphedema, transplantation rejection and cancers.</p>
</abstract>
<contract-num rid="EY1">R01 EY014048-05</contract-num>
<contract-num rid="EY1">R01 EY014048-04</contract-num>
<contract-num rid="EY1">R01 EY014048-03</contract-num>
<contract-num rid="EY1">R01 EY014048-02</contract-num>
<contract-num rid="EY1">R01 EY010101-15</contract-num>
<contract-num rid="EY1">R01 EY010101-14</contract-num>
<contract-num rid="EY1">P30 EY001792-30</contract-num>
<contract-sponsor id="EY1">National Eye Institute : NEI</contract-sponsor>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002742 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002742 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Corpus |type= RBID |clé= |texte= }}
![]() | This area was generated with Dilib version V0.6.31. | ![]() |